Global Encapsulated Live Cell 麻豆原创 Research Report 2023

Publication ID:

PB504233902

Publication Date:

April 17, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host鈥檚 genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
Highlights
The global Encapsulated Live Cell market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Encapsulated Live Cell is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Encapsulated Live Cell is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Encapsulated Live Cell in Diabetes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Encapsulated Live Cell include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc. and Altucell, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Encapsulated Live Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Encapsulated Live Cell.
The Encapsulated Live Cell market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Encapsulated Live Cell market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Encapsulated Live Cell companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Segment by Type
Alginate
Chitosan
Cellulose
Others
Segment by Application
Diabetes
Cancer
Epilepsy
Parkinson
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Encapsulated Live Cell companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Encapsulated Live Cell 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Alginate
1.2.3 Chitosan
1.2.4 Cellulose
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Encapsulated Live Cell 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Cancer
1.3.4 Epilepsy
1.3.5 Parkinson
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Encapsulated Live Cell 麻豆原创 Perspective (2018-2029)
2.2 Encapsulated Live Cell Growth Trends by Region
2.2.1 Global Encapsulated Live Cell 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Encapsulated Live Cell Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Encapsulated Live Cell Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Encapsulated Live Cell 麻豆原创 Dynamics
2.3.1 Encapsulated Live Cell Industry Trends
2.3.2 Encapsulated Live Cell 麻豆原创 Drivers
2.3.3 Encapsulated Live Cell 麻豆原创 Challenges
2.3.4 Encapsulated Live Cell 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Encapsulated Live Cell Players by Revenue
3.1.1 Global Top Encapsulated Live Cell Players by Revenue (2018-2023)
3.1.2 Global Encapsulated Live Cell Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Encapsulated Live Cell 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Encapsulated Live Cell Revenue
3.4 Global Encapsulated Live Cell 麻豆原创 Concentration Ratio
3.4.1 Global Encapsulated Live Cell 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Encapsulated Live Cell Revenue in 2022
3.5 Encapsulated Live Cell Key Players Head office and Area Served
3.6 Key Players Encapsulated Live Cell Product Solution and Service
3.7 Date of Enter into Encapsulated Live Cell 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Encapsulated Live Cell Breakdown Data by Type
4.1 Global Encapsulated Live Cell Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Encapsulated Live Cell Forecasted 麻豆原创 Size by Type (2024-2029)
5 Encapsulated Live Cell Breakdown Data by Application
5.1 Global Encapsulated Live Cell Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Encapsulated Live Cell Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Encapsulated Live Cell 麻豆原创 Size (2018-2029)
6.2 North America Encapsulated Live Cell 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Encapsulated Live Cell 麻豆原创 Size by Country (2018-2023)
6.4 North America Encapsulated Live Cell 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Encapsulated Live Cell 麻豆原创 Size (2018-2029)
7.2 Europe Encapsulated Live Cell 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Encapsulated Live Cell 麻豆原创 Size by Country (2018-2023)
7.4 Europe Encapsulated Live Cell 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Encapsulated Live Cell 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Encapsulated Live Cell 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Encapsulated Live Cell 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Encapsulated Live Cell 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Encapsulated Live Cell 麻豆原创 Size (2018-2029)
9.2 Latin America Encapsulated Live Cell 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Encapsulated Live Cell 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Encapsulated Live Cell 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Encapsulated Live Cell 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Encapsulated Live Cell 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Encapsulated Live Cell 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Encapsulated Live Cell 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viacyte, Inc.
11.1.1 Viacyte, Inc. Company Detail
11.1.2 Viacyte, Inc. Business Overview
11.1.3 Viacyte, Inc. Encapsulated Live Cell Introduction
11.1.4 Viacyte, Inc. Revenue in Encapsulated Live Cell Business (2018-2023)
11.1.5 Viacyte, Inc. Recent Development
11.2 Living Cell Technologies Ltd.
11.2.1 Living Cell Technologies Ltd. Company Detail
11.2.2 Living Cell Technologies Ltd. Business Overview
11.2.3 Living Cell Technologies Ltd. Encapsulated Live Cell Introduction
11.2.4 Living Cell Technologies Ltd. Revenue in Encapsulated Live Cell Business (2018-2023)
11.2.5 Living Cell Technologies Ltd. Recent Development
11.3 Sigilon Therapeutics, Inc
11.3.1 Sigilon Therapeutics, Inc Company Detail
11.3.2 Sigilon Therapeutics, Inc Business Overview
11.3.3 Sigilon Therapeutics, Inc Encapsulated Live Cell Introduction
11.3.4 Sigilon Therapeutics, Inc Revenue in Encapsulated Live Cell Business (2018-2023)
11.3.5 Sigilon Therapeutics, Inc Recent Development
11.4 Sernova Corporation
11.4.1 Sernova Corporation Company Detail
11.4.2 Sernova Corporation Business Overview
11.4.3 Sernova Corporation Encapsulated Live Cell Introduction
11.4.4 Sernova Corporation Revenue in Encapsulated Live Cell Business (2018-2023)
11.4.5 Sernova Corporation Recent Development
11.5 PharmaCyte Biotech Inc
11.5.1 PharmaCyte Biotech Inc Company Detail
11.5.2 PharmaCyte Biotech Inc Business Overview
11.5.3 PharmaCyte Biotech Inc Encapsulated Live Cell Introduction
11.5.4 PharmaCyte Biotech Inc Revenue in Encapsulated Live Cell Business (2018-2023)
11.5.5 PharmaCyte Biotech Inc Recent Development
11.6 Gloriana Therapeutics
11.6.1 Gloriana Therapeutics Company Detail
11.6.2 Gloriana Therapeutics Business Overview
11.6.3 Gloriana Therapeutics Encapsulated Live Cell Introduction
11.6.4 Gloriana Therapeutics Revenue in Encapsulated Live Cell Business (2018-2023)
11.6.5 Gloriana Therapeutics Recent Development
11.7 Kadimastem
11.7.1 Kadimastem Company Detail
11.7.2 Kadimastem Business Overview
11.7.3 Kadimastem Encapsulated Live Cell Introduction
11.7.4 Kadimastem Revenue in Encapsulated Live Cell Business (2018-2023)
11.7.5 Kadimastem Recent Development
11.8 Beta-O2 Technologies, Inc.
11.8.1 Beta-O2 Technologies, Inc. Company Detail
11.8.2 Beta-O2 Technologies, Inc. Business Overview
11.8.3 Beta-O2 Technologies, Inc. Encapsulated Live Cell Introduction
11.8.4 Beta-O2 Technologies, Inc. Revenue in Encapsulated Live Cell Business (2018-2023)
11.8.5 Beta-O2 Technologies, Inc. Recent Development
11.9 Altucell, Inc.
11.9.1 Altucell, Inc. Company Detail
11.9.2 Altucell, Inc. Business Overview
11.9.3 Altucell, Inc. Encapsulated Live Cell Introduction
11.9.4 Altucell, Inc. Revenue in Encapsulated Live Cell Business (2018-2023)
11.9.5 Altucell, Inc. Recent Development
11.10 Diatranz Otsuka Ltd
11.10.1 Diatranz Otsuka Ltd Company Detail
11.10.2 Diatranz Otsuka Ltd Business Overview
11.10.3 Diatranz Otsuka Ltd Encapsulated Live Cell Introduction
11.10.4 Diatranz Otsuka Ltd Revenue in Encapsulated Live Cell Business (2018-2023)
11.10.5 Diatranz Otsuka Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.